Reported Consolidated quarterly numbers for Panacea Biotec are:
Net Sales at Rs 136.46 crore in March 2024 up 5.84% from Rs. 128.93 crore in March 2023.
Story continues below Advertisement
Quarterly Net Loss at Rs. 1.43 crore in March 2024 up 88.72% from Rs. 12.68 crore in March 2023.
EBITDA stands at Rs. 4.77 crore in March 2024 down 49.2% from Rs. 9.39 crore in March 2023.
Panacea Biotec shares closed at 133.37 on June 13, 2024 (NSE) and has given -19.95% returns over the last 6 months and -3.11% over the last 12 months.
Story continues below Advertisement
| Panacea Biotec | | Consolidated Quarterly Results | in Rs. Cr. |
|
| Mar'24 | Dec'23 | Mar'23 | | Net Sales/Income from operations | 136.46 | 150.50 | 128.93 | | Other Operating Income | -- | -- | -- | | Total Income From Operations | 136.46 | 150.50 | 128.93 | | EXPENDITURE | | Consumption of Raw Materials | 45.53 | 47.83 | 59.51 | | Purchase of Traded Goods | -0.49 | 1.09 | -- | | Increase/Decrease in Stocks | 4.71 | 18.40 | -2.03 | | Power & Fuel | -- | -- | -- | | Employees Cost | 38.43 | 37.65 | 30.55 | | Depreciation | 8.81 | 9.11 | 9.51 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 54.32 | 45.68 | 46.57 | | P/L Before Other Inc., Int., Excpt. Items & Tax | -14.85 | -9.26 | -15.18 | | Other Income | 10.81 | 5.68 | 15.06 | | P/L Before Int., Excpt. Items & Tax | -4.04 | -3.58 | -0.12 | | Interest | 0.82 | 0.85 | 1.05 | | P/L Before Exceptional Items & Tax | -4.86 | -4.43 | -1.17 | | Exceptional Items | 2.74 | 2.78 | 19.38 | | P/L Before Tax | -2.12 | -1.65 | 18.21 | | Tax | -0.13 | 0.55 | 30.89 | | P/L After Tax from Ordinary Activities | -1.99 | -2.20 | -12.68 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | -1.99 | -2.20 | -12.68 | | Minority Interest | 0.56 | -- | -- | | Share Of P/L Of Associates | -- | -- | -- | | Net P/L After M.I & Associates | -1.43 | -2.20 | -12.68 | | Equity Share Capital | 6.13 | 6.13 | 6.13 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | -0.23 | -0.37 | -2.07 | | Diluted EPS | -0.23 | -0.37 | -2.07 | | EPS After Extra Ordinary | | Basic EPS | -0.23 | -0.37 | -2.07 | | Diluted EPS | -0.23 | -0.37 | -2.07 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
